Tiotropium inhalation solution for nebulization

US10632109B2 · kind B2 · utility

Assignee

• GLENMARK SPECIALTY S.A. · CH

Inventors

• Ulhas R. Dhuppad · Jamkhed, IN
• Franciscus Koppenhagen · Salem, US
• Sunil Chaudhari · Nashik, IN
• Suresh Rajurkar · Nashik, IN
• Chandrakant Dhatrak · Jamkhed, IN
• Alkesh Kasliwal · Nanded, IN

Key dates

• Filing date: Apr 5, 2019
• Grant date: Apr 28, 2020
• Expiry date: Apr 5, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P11/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.